News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Acerus (TRLPF) Reports Third Quarter 2016 Financial Results



11/2/2016 10:33:04 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) today reported its financial results for the three and nine-month period ended September 30, 2016. Unless otherwise noted, all amounts are in U.S. dollars.

“During the quarter, Aytu Bioscience began commercializing NATESTO® in the U.S. and the demand for our product has been extremely encouraging and on a path to surpass previous highs. We are equally excited by the early response to the Canadian launch of NATESTO™ and look forward to sharing our successes in the coming months,” said Tom Rossi, President and Chief Executive Officer of Acerus.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES